ArticleCase reports in oncology
Remarkable Response to Cisplatin-Based Chemotherapy and Long-Term Remission in a Young Male with Widespread Extragonadal Choriocarcinoma: A Case Report and Literature Review.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Choriocarcinoma is a rare and aggressive germ cell tumor that presents significant diagnostic challenges, particularly in males, where it is typically found in the gonads. Most patients present with advanced disease, often exhibiting symptoms related to metastatic spread, such as shortness of breath, cough, and hemoptysis. The rarity of extragonadal choriocarcinoma and its non-specific presentation make early diagnosis difficult, emphasizing the need for a multidisciplinary approach to treatment. Case Presentation: A 31-year-old male presented with progressive shortness of breath, cough, and hemoptysis for over a month. Initial imaging revealed multiple pulmonary nodules and a large necrotic retroperitoneal mass, along with liver metastases. The patient's β-human chorionic gonadotropin (β-hCG) levels were markedly elevated, raising suspicion of choriocarcinoma, subsequently confirmed through biopsy. Given the rapid clinical deterioration, chemotherapy with cisplatin and etoposide was initiated. The patient responded well to treatment, with a significant reduction in tumor and metastasis size. Over 30 months of follow-up, the patient showed continued clinical improvement with no evidence of disease recurrence. Conclusion: Extragonadal choriocarcinoma is a highly aggressive and rare malignancy that poses significant diagnostic and therapeutic challenges. This case underscores the importance of early intervention and the need for ongoing research to improve outcomes in these patients. A multidisciplinary approach is crucial for optimal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.